Impax Asset Management Group plc raised its holdings in shares of TriMas Co. (NASDAQ:TRS – Free Report) by 216.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 410,000 shares of the industrial products company’s stock after buying an additional 280,431 shares during the period. Impax Asset Management Group plc owned about 1.01% of TriMas worth $10,467,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of TRS. Innealta Capital LLC bought a new stake in shares of TriMas in the second quarter worth $26,000. Quantbot Technologies LP increased its stake in shares of TriMas by 5.7% in the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock worth $239,000 after buying an additional 478 shares during the last quarter. Aristides Capital LLC bought a new stake in shares of TriMas in the second quarter worth $245,000. Algert Global LLC increased its stake in shares of TriMas by 4.2% in the second quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock worth $403,000 after buying an additional 639 shares during the last quarter. Finally, Inspire Investing LLC increased its stake in shares of TriMas by 17.4% in the third quarter. Inspire Investing LLC now owns 16,155 shares of the industrial products company’s stock worth $412,000 after buying an additional 2,389 shares during the last quarter. 99.42% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several analysts have weighed in on TRS shares. BWS Financial reiterated a “buy” rating and set a $40.00 target price on shares of TriMas in a research note on Tuesday, November 5th. StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a research note on Wednesday.
TriMas Stock Down 0.2 %
TRS stock opened at $25.54 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. TriMas Co. has a 1-year low of $22.45 and a 1-year high of $28.51. The firm has a fifty day moving average price of $26.13 and a two-hundred day moving average price of $25.87. The firm has a market cap of $1.04 billion, a price-to-earnings ratio of 39.91 and a beta of 0.66.
TriMas (NASDAQ:TRS – Get Free Report) last released its earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.14). The business had revenue of $229.36 million for the quarter, compared to the consensus estimate of $239.33 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The firm’s revenue for the quarter was down 2.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.57 EPS. Research analysts predict that TriMas Co. will post 1.74 EPS for the current year.
TriMas Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 12th. Investors of record on Tuesday, November 5th were issued a $0.04 dividend. This represents a $0.16 annualized dividend and a yield of 0.63%. The ex-dividend date was Tuesday, November 5th. TriMas’s payout ratio is currently 25.00%.
About TriMas
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Further Reading
- Five stocks we like better than TriMas
- What are earnings reports?
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What Does Downgrade Mean in Investing?
- Top-Performing Non-Leveraged ETFs This Year
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS – Free Report).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.